How Impactful Is Stock Epinephrine for Anaphylaxis at Schools?
(MedPage Today) -- Most schools that keep a stock epinephrine autoinjector available to treat allergic reactions also require children with known severe allergies to bring their own, a survey of school nurses found. While 87% of their schools...
The effectiveness of stock epinephrine autoinjectors in treating anaphylactic emergencies at schools is significant, even when personal epinephrine supplies are mandatory, according to a survey of school nurses presented at the American College of Allergy, Asthma & Immunology (ACAAI) annual meeting by Mahi K. Singh, MD of the University of Chicago Medicine.
Of the schools surveyed, 87% had stock epinephrine available, yet 71.3% still required students with severe allergies to bring their own personal supply. Schools without stock were four and a half times more likely to report unavailability of epinephrine when needed compared to those with stock (P < 0.001).
Dr. Singh emphasized that having stock epinephrine is extremely helpful during anaphylactic emergencies, even when students are also required to carry personal supplies. However, she noted a high rate of unused, expired autoinjectors, suggesting potential waste. Despite the infrequency of epinephrine administration (97.0% of schools reported never using more than two devices in a single day), most nurses surveyed (73.6%) still supported a dual-coverage model, which combines stock and personal supplies.
They believe switching to a stock-only model could reduce excess supplies, administrative burden, and costs. Yet, some nurses express discomfort with this model due to concerns about school nurses' comfort levels and the presence of school nurses.
Dr. Jay Lieberman, MD of the University of Tennessee Health Science Center, mentioned that newer forms of epinephrine, such as nasal sprays and sublingual films, might offer better stability and ease of administration, potentially overcoming hesitancy and other obstacles. These newer formulations not only show better stability under harsh conditions but also have longer shelf lives, which could benefit schools that might stock them instead of autoinjectors.
However, the study's limitations include its low response rate, the influence of Illinois policies, and the generalizability of the findings to schools without dedicated school nurses.
Written by urgent.news from MedPage Today's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.